10x Genomics (TXG) Change in Cash (2018 - 2026)

10x Genomics has disclosed Change in Cash across 9 years of filings, most recently posting $12.2 million for Q2 2026.

• In Q2 2026, Change in Cash fell 40.79% year-over-year to $12.2 million; the TTM figure through Jun 2026 stood at $104.8 million (up 485.87% YoY), while the FY2025 annual figure was $129.9 million, up 953.64% from the prior year.
• Change in Cash came in at $12.2 million for Q2 2026 at 10x Genomics, down from $16.3 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $112.4 million in Q1 2023 to a low of -$276.0 million in Q1 2022.
• Average Change in Cash over 5 years is -$5.2 million, with a median of $14.3 million recorded in 2026.
• Year-over-year, Change in Cash sank 906.61% in 2022 and jumped 1041.88% in 2025.
• Over 5 years, Change in Cash stood at -$14.2 million in 2022, then jumped by 413.77% to $44.5 million in 2023, then plunged by 221.43% to -$54.1 million in 2024, then soared by 176.27% to $41.3 million in 2025, then plunged by 70.36% to $12.2 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $12.2 million in Q2 2026, $16.3 million in Q1 2026, and $41.3 million in Q4 2025.